1. Home
  2. ONCY vs KF Comparison

ONCY vs KF Comparison

Compare ONCY & KF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • KF
  • Stock Information
  • Founded
  • ONCY 1998
  • KF 1984
  • Country
  • ONCY Canada
  • KF United States
  • Employees
  • ONCY N/A
  • KF N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • KF Investment Managers
  • Sector
  • ONCY Health Care
  • KF Finance
  • Exchange
  • ONCY Nasdaq
  • KF Nasdaq
  • Market Cap
  • ONCY 86.1M
  • KF 95.9M
  • IPO Year
  • ONCY 1999
  • KF N/A
  • Fundamental
  • Price
  • ONCY $0.76
  • KF $19.95
  • Analyst Decision
  • ONCY Strong Buy
  • KF
  • Analyst Count
  • ONCY 2
  • KF 0
  • Target Price
  • ONCY $4.00
  • KF N/A
  • AVG Volume (30 Days)
  • ONCY 359.4K
  • KF 18.4K
  • Earning Date
  • ONCY 11-12-2024
  • KF 01-01-0001
  • Dividend Yield
  • ONCY N/A
  • KF N/A
  • EPS Growth
  • ONCY N/A
  • KF N/A
  • EPS
  • ONCY N/A
  • KF N/A
  • Revenue
  • ONCY N/A
  • KF N/A
  • Revenue This Year
  • ONCY N/A
  • KF N/A
  • Revenue Next Year
  • ONCY N/A
  • KF N/A
  • P/E Ratio
  • ONCY N/A
  • KF N/A
  • Revenue Growth
  • ONCY N/A
  • KF N/A
  • 52 Week Low
  • ONCY $0.76
  • KF $18.30
  • 52 Week High
  • ONCY $1.53
  • KF $25.56
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 26.96
  • KF 43.74
  • Support Level
  • ONCY $0.91
  • KF $19.55
  • Resistance Level
  • ONCY $0.88
  • KF $20.20
  • Average True Range (ATR)
  • ONCY 0.04
  • KF 0.31
  • MACD
  • ONCY -0.01
  • KF 0.07
  • Stochastic Oscillator
  • ONCY 11.12
  • KF 67.46

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

About KF Korea Fund Inc. (The) New

Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.

Share on Social Networks: